These conditions include: Risk factors for systolic heart failure include having a history of smoking, misusing alcohol or drugs, and being overweight or obese. Blood tests can also help diagnose ...

Drugmaker USV has introduced OnArni, a fixed dose combination of Sacubitril and Valsartan, for the management of heart failure ... with their versions of the drug. Prashant Tewari, USV Managing ...

This is an exercise for you, not both of you. 4. Try to figure out if you are afraid of getting your heart broken (fear he is thinking of leaving you) or wondering if this is the right person for ...

An analysis of the FINEARTS-HF trial, which showed finerenone's benefits in heart failure outcomes, shows no significant ...

Researchers from the Heart Center of the University Medical Center Göttingen (UMG) led by Priv.-Doz. Dr. Sören Brandenburg have identified a protein that plays a central role in the heart's adaptation ...

A new single-dose treatment demonstrates potential for improving heart repair following heart attacks in preclinical studies. Researchers at the Eli and Edythe Broad Center of Regenerative Medicine an ...

Oct 16 (Reuters) - Novartis (NOVN.S), opens new tab has lost a bid to keep a generic version of its top-selling heart failure drug Entresto off the U.S. market by blocking regulators from ...

Congestive heart failure is a disease state distinguished by the regular presence of both renal and hepatic abnormalities in drug handling. One such abnormality involves flaws in the process of ...

Experimental Drug Engineered to Prevent Heart Failure After Heart Attacks Oct. 24, 2024 — An experimental therapeutic monoclonal antibody therapy could become the first to directly enhance ...

Moderna is already riding high on the strength of its mRNA-based COVID-19 vaccine, but the broader potential of its technology has been shown in a new AstraZeneca-partnered candidate for heart ...